Cabiralizumab (Anti-CSF1R / M-CSFR / CD115)
Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) is an monoclonal antibody (MAb) targeting CSF1R. It can be used in the research of rheumatoid arthritis (RA), melanoma, kidney cancer, or non-small cell lung cancer. MW :146.3 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2644 |
Sku # | A2644-1mg*25 |
Pricing | 1mg*25, $2970.00 |